Gilton Marques Fonseca

Dr. Gilton Marques Fonseca

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2017 in Histopathology
Verified
Journal Article
Closed access
PDF file
GFGilton Marques Fonseca
Gilton Marques Fonseca
PHPaulo Herman
Paulo Herman
SFSheila F Faraj
Sheila F Faraj
JKJaime A P Kruger
Jaime A P Kruger
FCFabricio F Coelho
Fabricio F Coelho
EMEvandro S de Mello
Evandro S de Mello

1 June 2014 in Surgery
Verified
Journal Article
Closed access
RLRenato M. Lupinacci
Renato M. Lupinacci
EMEvandro Sobroza Mello
Evandro Sobroza Mello
FCFabrício Ferreira Coelho
Fabrício Ferreira Coelho
JKJaime Arthur Pirolla Kruger
Jaime Arthur Pirolla Kruger
MPMarcos Vinicius Perini
Marcos Vinicius Perini
PHPaulo Herman
Paulo Herman

1 January 2014 in World Journal of Gastrointestinal Surgery
Verified
Journal Article
Open access
GFGilton Marques Fonseca
Gilton Marques Fonseca
AVAntonio Drauzio Varella
Antonio Drauzio Varella
FCFabricio Ferreira Coelho
Fabricio Ferreira Coelho
EAEmerson Shigueaki Abe
Emerson Shigueaki Abe
RDRodrigo Blanco Dumarco
Rodrigo Blanco Dumarco
PHPaulo Herman
Paulo Herman
Downstaging and resection after neoadjuvant therapy for fibrolamellar hepatocellular carcinoma

15 February 2018 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
GFGilton Marques Fonseca
Gilton Marques Fonseca
EMEvandro S. de Mello
Evandro S. de Mello
SFSheila F. Faraj
Sheila F. Faraj
JKJaime A. P. Kruger
Jaime A. P. Kruger
FCFabricio F. Coelho
Fabricio F. Coelho
PHPaulo Herman
Paulo Herman

1 June 2014 in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Verified
Journal Article
Open access
PDF file
FCFabricio Ferreira Coelho
Fabricio Ferreira Coelho
MPMarcos Vinicius Perini
Marcos Vinicius Perini
JKJaime Arthur Pirola Kruger
Jaime Arthur Pirola Kruger
GFGilton Marques Fonseca
Gilton Marques Fonseca
RARaphael Leonardo Cunha de Araújo
Raphael Leonardo Cunha de Araújo
PHPaulo Herman
Paulo Herman
INTRODUCTION: The treatment of portal hypertension is complex and the the best strategy depends on the underlying disease (cirrhosis vs. schistosomiasis), patient's clinical condition and time on it is performed (during an acute episode of variceal bleeding or electively, as pre-primary, primary or secondary prophylaxis). With the advent of new pharmacological options and technical development of endoscopy and interventional radiology treatment of portal hypertension has changed in recent decades. AIM: To review the strategies employed in elective and emergency treatment of variceal bleeding in cirrhotic and schistosomotic patients. METHODS: Survey of publications in PubMed, Embase, Lilacs, SciELO and Cochrane databases through June 2013, using the headings: portal hypertension, esophageal and gastric varices, variceal bleeding, liver cirrhosis, schistosomiasis mansoni, surgical treatment, pharmacological treatment, secondary prophylaxis, primary prophylaxis, pre-primary prophylaxis. CONCLUSION: Pre-primary prophylaxis doesn't have specific treatment strategies; the best recommendation is treatment of the underlying disease. Primary prophylaxis should be performed in cirrhotic patients with beta-blockers or endoscopic variceal ligation. There is controversy regarding the effectiveness of primary prophylaxis in patients with schistosomiasis; when indicated, it is done with beta-blockers or endoscopic therapy in high-risk varices. Treatment of acute variceal bleeding is systematized in the literature, combination of vasoconstrictor drugs and endoscopic therapy, provided significant decline in mortality over the last decades. TIPS and surgical treatment are options as rescue therapy. Secondary prophylaxis plays a fundamental role in the reduction of recurrent bleeding, the best option in cirrhotic patients is the combination of pharmacological therapy with beta-blockers and endoscopic band ligation. TIPS or surgical treatment, are options for controlling rebleeding on failure of secondary prophylaxis. Despite the increasing evidence of the effectiveness of pharmacological and endoscopic treatment in schistosomotic patients, surgical therapy still plays an important role in secondary prophylaxis.

1 September 2016 in Pancreatology
Verified
Journal Article
Closed access
MMMarcel c c Machado
Marcel c c Machado
GFGilton Marques Fonseca
Gilton Marques Fonseca
LMLuciana Rodrigues de Meirelles
Luciana Rodrigues de Meirelles
FZFlavia Fernandes Silva Zacchi
Flavia Fernandes Silva Zacchi
RBRegis Otaviano Franca Bezerra
Regis Otaviano Franca Bezerra